Updated annually, the BP is the official, authoritative collection of standards for UK medicinal substances for human and veterinary use. The BP 2022 includes almost 4,000 monographs. All monographs and requirements of the European Pharmacopoeia are also reproduced in the BP, making it an essential reference for students, lecturers and researchers. The online product provides subscribers with access to the British pharmacopoeia 2022, British pharmacopoeia (veterinary) 2022 and the current edition and supplements of Britsh approved names. Concurrent access to the 2014 onwards is also available

Updated annually, the British Pharmacopoeia (BP) is the only comprehensive collection of authoritative official standards for UK pharmaceutical substances and medicinal products. It includes approximately 4,000 monographs which are legally enforced by the Human Medicines Regulations 2012. Where a BP monograph exists, medicinal products or active pharmaceutical ingredients sold or supplied in the UK must comply with the relevant monograph.All monographs and requirements of the European Pharmacopoeia (Ph. Eur.) are reproduced in the BP, making the BP a convenient and fully comprehensive set of standards that can be used across Europe and beyond.

New, legally enforced standards, available from 1 August 2021.All European Pharmacopoeia texts included.Updated annually, the British Pharmacopoeia (BP) is the only comprehensive collection of authoritative official standards for UK pharmaceutical substances and medicinal products.It includes approximately 4,000 monographs which are legally enforced by the Human Medicines Regulations 2012. Medicinal products or active pharmaceutical ingredients sold or supplied in the UK must comply with the relevant monograph.All monographs and requirements of the European Pharmacopoeia (Ph. Eur.) are reproduced in the BP, making the BP a convenient and fully comprehensive set of standards that can be used across Europe and beyond. New for the BP 2022.The BP 2022 supersedes the BP 2021 and becomes legally effective on 1 January 2022. This edition incorporates new monographs from both the BP and Ph. Eur. along with a significant number of revised monographs;(i) 20 new BP monographs, 38 new Ph. Eur. monographs: (ii) 130 amended BP monographs; (iii) All monographs from the Ph. Eur. 10th edition as amended by Supplements 10.1 to 10.5 are included; (iv) Ph. Eur. supplements 10.6, 10.7, and 10.8 included as in-year online and download product updates.The BP 2022 packageThe complete package is a great value-for-money option including:(i) A six-volume printed edition, including the BP (Veterinary) 2022; (ii) A single-user online licence(iii) A single-user download for offline use

The British Pharmacopoeia (BP) 2017 supersedes the BP 2016 and becomes legally effective on 1 January 2017. This edition incorporates new BP and European Pharmacopoeia monographs and a significant number of revised monographs. Also included is new information for unlicensed medicines and DNA barcoding. Updated annually, the BP is the only comprehensive collection of authoritative official standards for UK pharmaceutical substances and medicinal products. The BP 2017 includes almost 4,000 monographs which are legally enforced by the Human Medicines Regulations 2012. Where a pharmacopoeial monograph exists, medicinal products sold or supplied in the UK must comply with the relevant monograph. All monographs and requirements of the European Pharmacopoeia are also reproduced in the BP.

The Tarascon Pharmacopoeia 2010 Library Edition is a convenient, organized, and concise manual packed with vital drug information and meticulously peer reviewed by experts and clinicians of multiple specialties. It details typical drug dosing, available trade and generic formulations, metabolism, safety in pregnancy and lactation, black-box warnings, notes regarding adverse effects and drug interactions, and a table of cytochrome P450 isozymes, and much more.